DatasetName,HELZ_S(1126) HELZ_S(1176) HELZ_S(1177) HELZ_S(1178) HELZ_S(1179) HELZ_S(1180) HELZ_S(1247) HELZ_S(1248) HELZ_S(1311) HELZ_S(1316) HELZ_S(1317) HELZ_S(1318) HELZ_S(1442) HELZ_S(1584) HELZ_S(1614) HELZ_S(1615) HELZ_S(1620) HELZ_S(1621) HELZ_S(1624) HELZ_S(1738) HELZ_S(1739) HELZ_S(1740) HELZ_S(1741) HELZ_S(1742) HELZ_S(1744) HELZ_S(1761) HELZ_S(1763) HELZ_S(1775) HELZ_S(1784) HELZ_S(1883) HELZ_S(1884) HELZ_S(248) HELZ_S(3) HELZ_S(629) HELZ_S(973) HELZ_T(1160) HELZ_T(1163) HELZ_T(1164) HELZ_T(1296) HELZ_T(1625) HELZ_T(1736) HELZ_T(1776) HELZ_Y(1162) HELZ_Y(1251),HELZ_S(1312) HELZ_S(1320) HELZ_S(1898)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,0.49525807860234994,
FSO2013_Ratio M/L normalized Rep3,0.505141239931683,
SR2019_MCF7_Biol_repl_3,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,0.49907513682851723,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,0.4980893208618578,
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,,
RKK2015_TNF-α/basal,,
JJ2018_Ratio H/M normalized pP2,,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,0.4948242177243615,
ZX2022_Control Replicate 2,0.49769274562255544,
HS2024_6_B_T3,0.4990084075505816,
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,0.49630573337363476,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,0.4879428713242635,
SR2019_MDAMB231_Biol_repl_4,,
GF2025_P2_Sph,0.4944687337933747,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,0.4984734795792818,
DB2022_Intensity L2,,
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,0.4959001954267563,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,0.4996963789076992,
FSO2013_Ratio M/L normalized Rep1___1,0.49668611056875867,
SAS2015_AZD/DMSO_Exp3,,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,0.49734055126787136,
RB2022_5_PreEndurance,0.49840496464208833,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,0.497960589542811,
WZ2023_Pu_010_30min,0.4976370331694349,
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,0.49745688878377287,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,0.496570256324383,
RB2022_8_RecoveryEndurance,0.4978385903622694,
KBE2022_Log2_Ex_14_U,,
FSO2013_Ratio M/L normalized Rep3___3,0.5073820587884996,
AH2018_TMTMS3_1_C,0.4988856351391267,
JJ2018_Ratio H/L normalized___1,,
ZQ2022_C2,,
RB2022_5_PreSprint,0.4990771291512066,
PG2020_Intensity 8h_C,,
AH2018_SILAC_MR_2_N,0.49866384843419614,
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),0.4976116856142335,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,0.497904073117396,
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),,
UK2020_HCM_2,,
FSO2013_Ratio H/L normalized Rep2___2,0.4994751082817931,
EP2017_Pervanadate R#3 normalized log2 ratio,0.49420437856332156,
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,0.49800220861693584,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,0.4959559090950123,
GF2025_P6_Sph,0.4958906415366103,
RB2022_2_PreSprint,,
ZX2022_CB treated Replicate 3,0.4982642948172342,
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,0.5066963128716925,
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,0.496009849454247,
KBE2022_Log2_Ex_34_U,0.4976294600756522,
WZ2023_Pu_005_10min,0.5052087380342599,
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,0.4999728430448998,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,0.4963084748581631,
WZ2023_Pu_025_30min,0.49940647814522376,
AH2018_SILAC_MR_2_X,0.4986568800817748,
HS2024_4_PD_T2,0.49700543153203147,
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,0.4968578996607675,
FR2021_Norm.Intensity.B,,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,,
EJN2021_3_Rest_Basal,,
CR2017_Ratio Replicate 1.3,0.49425962291190007,
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,0.49626635468060337,
JJ2018_Ratio M/L normalized pP3,,
AH2018_SILAC_M_2_N,0.49602652891161275,
HS2024_7_PD_T2,0.5004233013529612,
FSO2013_Ratio H/L normalized Rep1___1,0.4976383306554487,
AH2018_LFQ_1_C,0.49833803347127115,
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,,
HS2024_3_B_N1,0.4947858343864276,
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,0.5016892087456702,
CK2022_11 40-1,0.49991813175060107,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,0.49616466872004233,
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,0.4973722516028871,
FSO2013_Ratio H/L normalized Rep2,0.5015890093654064,
WZ2023_Pu_005_20min,0.4926622907872689,
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,0.4929265321972094,
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,0.49772423473720356,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,0.4990057552601486,
AH2018_LFQ_M_1_C,0.4989671952026276,
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,,
HS2024_9_B_T2,0.49658192422278974,
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,0.49592078393031797,
FSO2013_Ratio M/L normalized Rep3___2,0.5028980899536565,
SR2019_BT549_Biol_repl_3,,
RCJD2014_20min_mean,0.5015815895107758,
FR2021_Norm.Intensity.H,0.496093095547257,
RB2022_2_PreStrength,,
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,0.49764599446249824,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,0.49712576755963145,
CK2022_1 200-1,0.49808118202507595,
PG2020_Intensity Mock_10h_D,0.4961566568114986,
SR2019_MCF10A_Biol_repl_2,,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,0.5029272831026599,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,
RB2022_6_RecoveryEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,0.4908494103146269,
RCJD2014_5min_1,0.492371827013516,
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,,
CR2017_Ratio Replicate 3.3,0.49177489713479705,
PG2020_Intensity 2h_C,,
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,0.4970381095344623,
KBE2022_Log2_Ex_8_T,,
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,0.5029885245195079,
RN2012_L11,,
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,0.4968340324953628,
HS2024_5_PD_T1,0.5040109752163625,
AH2018_LFQ_M_2_C,,
CK2022_3 40-1,0.4997479567999523,
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,0.4990705773598949,
YA2020_Reporter_intensity_Cancer_No.5,0.4965781164655569,
HH2022_Reporter intensity 8,0.4952747898369962,
ZQ2022_N2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,0.4931384038436739,
EJN2021_5_Rest_Basal,,
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,0.5049853952133719,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,0.4949029044608418,
YA2020_Reporter_intensity_Normal_No.1,0.4957789695018176,
HS2024_3_B_T1,0.49703476571280353,
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,0.49803211187348173,
RB2022_1_PostEndurance,0.4972682192942221,
CR2017_Ratio Replicate 3,0.49380495683356285,
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,,
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,0.49748893969751967,
HS2024_8_I_T3,0.49750885638575243,
CF2017_EOC 3,,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,0.5027076457524586,
DL2023_12h-2,0.4938486429700252,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,
WZ2023_Pu_010_20min,0.5065952013693381,
AS2011_Ratio H/L_3,,
CK2022_1 40-1,0.49986481836872976,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,0.49770465670009717,
KS2014_Intensity N3,0.49915195425212905,
RB2022_4_RecoveryEndurance,0.4958951217451981,
RB2022_5_RecoveryEndurance,0.4966609951413561,
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,,
FSO2013_Ratio H/M normalized Rep2,0.4894404385048785,
RAM2015_Log2 A,0.4994330930963654,
HS2024_8_PD_T1,0.4968427457722404,
JJ2018_Ratio H/L normalized pP2,,
CF2017_OSE 27,0.49816193065780323,
KS2014_Intensity E15_2,0.4973871252918412,
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,,
HS2024_7_I_T1,0.4960785695034962,
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,
SR2019_JIMT1_Biol_repl_1,,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,0.5011891386697456,
AH2018_SILAC_M_3_X,0.49664285520099705,
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,,
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,0.4979185091580643,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,0.4956962409964072,
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,0.49801324813742714,
HS2024_6_B_N1,0.5026526316761569,
KBE2022_Log2_Ex_27_T,0.5009018880784952,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),0.4983874489951068,
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,0.49474056197001093,
AH2018_SILAC_IT_3_X,0.4956802429560799,
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,,
FSO2013_Ratio M/L normalized Rep2,0.4979653909586034,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,0.49561238805367275,
SR2019_HCC1954_Biol_repl_2,,
CK2022_14 40-1,0.500850137008418,
RB2022_6_PreSprint,,
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,,
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,,
DL2023_control-1,,
AR2021_ALG 10 μM,0.493683555275122,
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,0.4934242998845831,
EJN2021_4_Rest_Ins,,
RN2012_H05,,
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,0.5013448824791659,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,0.4966207081706175,
EJN2021_1_Rest_Ins,,
HH2022_Reporter intensity 3,0.5008683655399871,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,0.5000338449960546,
JW2021_After_3,,
GF2025_P8_Sph,0.4973616145384893,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,,
AH2018_SILAC_2_N,0.4956798049375358,
CK2022_11 200-1,0.49872361934335224,
CK2022_12 200-1,0.49930268776153214,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,0.49609835840313815,
WZ2023_Su_010_20min,0.4905974089161843,
AH2018_TMTMS2_2_N,0.49895803386449544,
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,0.49823615763997187,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,
AH2018_TMTMS3_Pool,0.4937260421318021,
KS2014_Intensity N4,,
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,,
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,0.4985755318018324,
CK2022_14 200-1,0.5016249861678514,
SR2019_Hs578T_Biol_repl_1,,
RB2022_7_PostSprint,0.5023120338358501,
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,0.4933244554188947,
AST2020_anti-CD3+PDL2.2,0.4961018729338002,
PG2020_Intensity Mock_10h_A,0.49186618034255064,
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,,
SR2019_LM2_Biol_repl_4,,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,0.49873605770084595,
GF2025_P1_Adh,0.5006447737613212,
GF2025_P1_Sph,0.4945691394071448,
EJN2021_5_Ex_Basal,,
HS2024_7_I_T3,0.4963380019875864,
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,0.5031842820260586,
CF2017_EOC 1,,
CK2022_3 200-1,0.49776895479447075,
AH2018_LFQ_IT_3_C,0.4968687282108112,
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),,
RB2022_3_RecoverySprint,,
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,0.49916026664655644,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,0.4967015192112252,
HS2024_5_B_T1,0.5073511993966351,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,0.4977670303251143,
SR2019_MDAMB231_Biol_repl_2,,
HS2024_3_B_T2,0.4935859791918796,
RB2022_6_PreStrength,,
CK2022_2 40-1,0.500099337873846,
RB2022_1_PostSprint,0.4952724608591327,
CK2022_4 200-1,0.4980426822179535,
JW2021_Before_2,,
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,0.49811651355605024,
AR2021_ALG 1 μM,0.49823247188684655,
HS2024_4_B_T1,0.49758541167490516,
MV2014_Ratio M/H normalized A3___1 (10 min),0.49836704765204054,
SR2019_BT549_Biol_repl_4,,
EJN2021_1_Rest_Basal,,
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,0.4993549575865195,
CR2017_Ratio Replicate 3.2,0.4885601019465291,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,0.49909816694903425,
CK2022_9 16-1,0.4971197839168631,
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,
CK2022_13 200-1,0.5014411380550837,
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,,
CK2022_16 16-1,0.49860866508304974,
FS2019_db/db3,,
CK2022_15 40-1,0.5010456159052312,
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,0.48930677141574547,
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,0.498512034909839,
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,0.4961559532159432,
HS2024_5_PD_T3,0.49492869591824734,
AH2018_TMTMS3_3_X,0.49476153782000803,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,,
AH2018_LFQ_M_1_N,0.4988353304319357,
KBE2022_Log2_Ex_27_U,0.5008284068938245,
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,
AH2018_SILAC_M_1_N,0.49801997693392186,
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,,
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,0.4971502658691412,
YA2020_Reporter_intensity_Normal_No.4,0.496813747582217,
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,,
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,0.49710515067471306,
RN2012_L13,,
LG2023_Control-1_intensity,,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,,
SR2019_SKBR3_Biol_repl_3,,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,0.4974299706456552,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,0.5004281277693104,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,0.4918484640934661,
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,0.4999925529336785,
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,0.4930141056896964,
HH2022_Reporter intensity 6,0.49661250455296974,
RB2022_2_RecoveryStrength,,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,0.49219911252523635,
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,,
AH2018_TMTMS2_3_X,0.4996405119892755,
GF2025_P3_Adh,0.49549205474614993,
SR2019_JIMT1_Biol_repl_2,,
AH2018_TMTMS2_1_C,0.4987111567367563,
RM2024_Intensity D0-1___2,,
LY2019_P4+,0.49313765427459005,
KBE2022_Log2_Ex_19_U,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,,
LG2023_GSK3α-3_intensity,0.4955854948660185,
YA2020_Reporter_intensity_Cancer_No.1,0.49558960023619786,
AST2020_Control,0.49546280971852197,
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,0.4992394806688642,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,0.4921962416705053,
LG2023_Control-2_intensity,,
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,0.4975237586194102,
RB2022_7_RecoverySprint,0.49821933698233994,
YA2020_Reporter_intensity_Normal_No.3,0.4969986102417103,
HS2024_8_B_T2,0.49728147650358623,
AH2018_LFQ_1_X,0.49547809329963766,
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,0.4933041880053533,
FR2021_Norm.Intensity.M,,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,,
HH2022_Reporter intensity 1,0.5010880280476685,
HH2022_Reporter intensity 2,0.5010117462182424,
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,0.4964059973438326,
SR2019_MCF7_Biol_repl_1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,0.5013252750454924,
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,0.49415261297324437,
SR2019_LM2_Biol_repl_3,,
RB2022_4_RecoveryStrength,0.49763076084935937,
CR2017_Ratio Replicate 2,0.5029732218294917,
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,0.49951995112167447,
AR2021_KD 72h,0.5036508910237304,
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,0.49964919248512185,
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,0.49315681811707374,
KBE2022_Log2_Ex_9_U,0.49933372682689736,
AH2018_SILAC_M_3_N,0.4952978220500079,
KBE2022_Log2_Ex_13_T,,
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,,
PG2020_Intensity Mock_10h_C,0.4935182079058624,
CF2017_OSE 29,0.49698796890281566,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,,
HS2024_7_B_N2,0.49807149569648357,
PG2020_Intensity 10h_A,,
RN2012_L12,,
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,0.4960212929387098,
SAS2015_PLX/AZD_Exp1,,
FR2021_Norm.Intensity.A,0.4962953698990777,
FSO2013_Ratio H/M normalized Rep1___1,0.49386894112744434,
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),,
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,0.5000719309001634,
RB2022_7_RecoveryEndurance,0.4977703806371377,
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,,
TM2022_S2.12h.B,,
RN2012_L15,0.5008958550123221,
KS2014_Intensity pY_PV3,,
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,,
FSO2013_Ratio H/M normalized Rep2___2,0.4968247028838925,
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,0.49772024104164775,
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,0.49803643821183635,
RB2022_1_PreSprint,0.49588629822842994,
HS2024_4_I_N1,0.5001650733034823,
CK2022_7 200-1,0.4998658764813545,
CK2022_5 200-1,0.5000252907841501,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,0.5004496099766755,
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,,
AH2018_LFQ_2_C,,
AH2018_SILAC_MR_1_X,0.5003558005161448,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,0.4969129780450272,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,0.49791621301248595,
AH2018_SILAC_3_C,0.4960344923292897,
EJN2021_5_Rest_Ins,,
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,0.48785753013353744,
CK2022_4 16-1,0.496703952719372,
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,
EJN2021_2_Ex_Ins,,
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,0.4968151013883086,
SAS2015_PLX/DMSO_Exp1,,
SFR2015_HL_log2_ratio_avg_c,,
JJ2018_Ratio M/L normalized pP2,,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,,
FSO2013_Ratio H/L normalized Rep3,0.5034087211126452,
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,
JJ2018_Ratio M/L normalized,,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,0.49602149388525146,
KBE2022_Log2_Ex_9_T,0.49965575041259297,
AH2018_SILAC_IT_2_N,0.49475246571005244,
AH2018_SILAC_IT_1_X,0.4966730326613252,
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,0.5000821192342838,
UK2020_UA_2,,
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,0.4947478783409495,
WZ2023_Pe_025_20min,0.5089645794422041,
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,0.49750709288208966,
HS2024_4_I_N2,0.5043756978713074,
AH2018_TMTMS2_3_N,0.4993574559872526,
RN2012_H06,0.5007555652151715,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,0.500318192759162,
WZ2023_Su_005_30min,0.49704731105393235,
SR2019_HCC1419_Biol_repl_4,,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,,
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,,
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,0.49122742420948345,
WZ2023_Su_025_10min,0.5025379835672379,
AH2018_LFQ_IT_4_X,0.49626335982024583,
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,0.49575763695218045,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,0.5030088538427708,
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,0.4959659248423838,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,0.49599335716661236,
EP2017_Pervanadate R#1 log2 ratio,0.4978834002808023,
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,
KS2014_Intensity,0.49639362436565143,
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,,
LY2019_P7+,0.49552631845641915,
EP2017_Untreated R#1 normalized log2 ratio,0.5051888584522674,
RN2012_L10,,
PG2020_Intensity 4h_C,0.4957267427794656,
EP2017_Mitotic R#3 normalized log2 ratio,0.49217097925220926,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,0.4977548428156076,
RB2022_8_PostStrength,0.49588855261503556,
AH2018_SILAC_IT_2_X,0.4960516511741117,
HS2024_4_B_T3,0.5019389886417398,
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,0.5061768374113185,
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,,
HS2024_8_I_T2,0.48744094999076515,
KBE2022_Log2_Ex_6_U,,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,0.503687852983718,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,0.50210420407283,
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,0.4894028372234949,
GF2025_P9_Sph,0.49515112132254513,
CK2022_6 200-1,0.4997406443943309,
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,0.4942881498900013,
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,,
HS2024_4_I_T2,0.49919141075943735,
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,0.5002503059105695,
SAS2015_AZD/DMSO_Exp1,,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,0.4965311676469399,
HS2024_3_B_T3,0.4988883097825638,
MV2014_Ratio L/H normalized A3___2 (2 min),0.4976322678044991,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,
PG2020_Intensity 2h_D,,
EP2017_Untreated R#3 normalized log2 ratio,0.4956732053454793,
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,0.4998151777099832,
KS2014_Intensity pY_C4,,
CR2017_Ratio Replicate 3.5,0.49977867700622836,
RB2022_7_PostEndurance,,
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,,
EP2017_Pervanadate R#2 normalized log2 ratio,0.49316295998349013,
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,0.4968695773489404,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,0.500499539748014,
KBE2022_Log2_Ex_29_T,0.49915823730097064,
HS2024_7_I_T2,0.49841121948861067,
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,0.5000217317908637,
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,,
EJN2021_1_Ex_Basal,,
FR2021_Intensity.M,,
RB2022_2_PostSprint,,
AH2018_SILAC_MR_3_N,0.5007704286382225,
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,,
PG2020_Intensity CT_C,,
ZCP2016_Ratio H/L Rep 1,,
FS2019_db/db2,,
KS2014_Intensity pY_PV4,,
KBE2022_Log2_Ex_39_U,,
EP2017_Untreated R#3 log2 ratio,0.49575149261707757,
RB2022_2_PostStrength,,
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),0.4920390360482885,
CR2017_Ratio Replicate 3.4,0.5011015786619049,
HS2024_8_PD_T2,0.49326666961815013,
FS2019_Ctr2,,
RB2022_6_PreEndurance,,
FR2021_Norm.Intensity.G,0.4972580280632748,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,0.49179563671591886,
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,,
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,,
RB2022_3_PreSprint,,
CR2017_Ratio Replicate 2.3,0.4826191283994665,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,0.4960960668306974,
YA2020_Reporter_intensity_Normal_No.2,0.4963419811206384,
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,0.49799979186092896,
HS2024_3_PD_T3,0.5008150520446247,
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,0.4976636601262799,
RAM2015_Log2 C,0.4963179801783246,
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,0.4982331666743611,
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,,
CK2022_2 16-1,0.4972539468809789,
RAM2015_Log2 B,0.49976752465053575,
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,0.4947923148168653,
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,0.4982191527201071,
UK2020_HCM_5,,
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,0.4955672807337325,
HS2024_7_PD_T3,0.4993173430451003,
PG2020_Intensity Mock_10h_B,0.4934810352678532,
WZ2023_Su_025_30min,0.505942233737454,
AH2018_LFQ_4_N,0.49736205769029634,
CR2017_Ratio Replicate 1.2,0.5148711013597901,
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,,
HS2024_8_I_N1,0.5000878259972668,
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,0.49464865287617227,
AH2018_SILAC_M_1_X,0.4977560535407207,
RB2022_7_PreEndurance,0.4968514905500617,
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,0.4989959624766517,
LY2019_P6+,0.5038755916936377,
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,0.49899180417597927,
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,0.49861387772545657,
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,0.49330229340274356,
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,,
KS2014_Intensity C5,0.49897788634438006,
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,0.4983511641296427,
RB2022_3_PostStrength,,
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,0.5002181294815439,
SR2019_BT549_Biol_repl_1,,
AH2018_LFQ_M_4_N,0.4981297211649371,
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,,
AH2018_LFQ_2_X,0.49587025139918856,
PG2020_Intensity 2h_B,,
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,,
KS2014_Intensity E15_3,0.4970824777789412,
GF2025_P3_Sph,0.4923745011341687,
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,,
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,0.49913511373970043,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),0.4972025062958931,
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,0.4945990720532025,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,0.49765617053955113,
JJ2018_Ratio M/L normalized pP1,,
CR2017_Ratio Replicate 2.4,0.4987015181461312,
ZQ2022_N1,,
LY2019_P6-,0.49690082395129953,
RM2024_Intensity D2-3,,
UK2020_HCM_1,,
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,0.5001678777535953,
AH2018_LFQ_3_N,0.4976231119625773,
RKK2015_TNF-α/IKKb,,
SFR2015_HL_log2_ratio_std_b,,
UK2020_UA_1,,
KBE2022_Log2_Ex_13_U,,
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,0.4970538415576924,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,,
CK2022_7 40-1,0.5000063870564039,
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,0.4950043238030055,
SR2019_BT549_Biol_repl_2,,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,,
RB2022_5_PostEndurance,,
HS2024_5_PD_T2,0.49398534025781926,
WZ2023_Su_025_20min,0.49107341914419184,
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,0.497422053020971,
LY2019_P8-,0.500006437784092,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,0.4941660122141215,
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,0.5007532829172391,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,,
PG2020_Intensity 10h_D,,
RB2022_8_PreEndurance,0.49735927387517687,
HS2024_3_B_N2,0.5069564041523169,
EJN2021_4_Ex_Ins,,
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,,
EP2017_Pervanadate R#3 log2 ratio,0.4945775412870033,
FSO2013_Ratio M/L normalized Rep1___3,0.48607354260792995,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,0.4981975844929906,
RB2022_6_PostStrength,,
AH2018_SILAC_MR_3_C,0.4956606478634047,
AH2018_LFQ_M_4_C,0.49778856014828504,
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,0.49663656161847514,
MV2014_Ratio L/M normalized B2___1 (30 min),0.496476087874484,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,,
CK2022_6 40-1,0.49993848930928997,
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,,
LY2019_P3-,0.4969454814240148,
FR2021_Intensity.A,0.4959287202938961,
EJN2021_3_Ex_Ins,,
MV2014_Ratio M/L normalized A1___1 (2 min),0.49695333952256343,
WZ2023_Pe_005_30min,0.5063495039267735,
HS2024_8_PD_T3,0.49642109422045133,
EJN2021_3_Ex_Basal,,
AST2020_Control.1,0.49547844615830977,
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,,
FS2019_Ctr3,,
WZ2023_Pu_025_20min,0.49684124895326104,
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,
GF2025_P10_Adh,0.49504623240675266,
RB2022_1_RecoveryStrength,0.4969991388268763,
SR2019_HCC1954_Biol_repl_4,,
FR2021_Norm.Intensity.N,0.494899531293369,
HS2024_5_B_N1,0.49032928936044196,
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,0.4991483809697304,
RB2022_4_PreSprint,0.49735899639636866,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,0.4937607296600828,
HS2024_8_I_N2,0.49940858176024056,
RB2022_3_RecoveryStrength,,
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,0.5010258677186836,
LY2019_P8+,0.5055749408047623,
RB2022_2_RecoveryEndurance,,
JJ2018_Ratio H/M normalized pP2___1,,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,,
KS2014_Intensity pY_PV1,,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),0.49799813483798233,
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,0.49725256675077883,
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,,
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,,
LY2019_P2-,0.5027534838930481,
AH2018_LFQ_IT_1_X,,
JJ2018_Ratio H/L normalized pP3___1,,
RB2022_8_RecoveryStrength,0.4970134002487059,
WZ2023_Pe_005_20min,0.5059016522004957,
AST2020_Control.2,0.49580055817010693,
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,0.4969400940507907,
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,
HS2024_3_I_T1,0.49631782748915254,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,0.5000818995921695,
SR2019_MCF10A_Biol_repl_4,,
KS2014_Intensity pY_C5,,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,,
HS2024_5_B_T2,0.5022723675457069,
HS2024_6_I_T1,0.5021995900238218,
HS2024_5_B_T3,0.5005119011577457,
JJ2018_Ratio H/M normalized pP1___1,,
KBE2022_Log2_Ex_36_U,0.5006069750976865,
AH2018_TMTMS3_3_N,0.49570434535501806,
SR2019_HCC1419_Biol_repl_2,,
FR2021_Intensity.N,0.4948935861709423,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,0.5011262225610911,
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,0.49202223378336357,
KBE2022_Log2_Ex_36_T,0.5005735520028707,
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,0.5051434203271008,
KS2014_Intensity C2,0.4978611592598716,
FSO2013_Ratio H/L normalized Rep1___2,0.4929424313750761,
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,,
CK2022_9 200-1,0.4985149241323407,
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,0.498354636884933,
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,0.5021643778463304,
RBK2021_1332T Late,,
LY2019_P1-,0.49596537844690575,
RKK2015_TNF-α/basal.1,,
RKK2015_TNF-α/TNF-α+SC-514,,
CR2017_Ratio Replicate 2.5,0.49268764456702924,
HS2024_3_I_T3,0.49989121339206855,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,0.49865940716972956,
ZQ2022_C3,,
EJN2021_3_Rest_Ins,,
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,,
FSO2013_Ratio H/M normalized Rep3___2,0.503344957751303,
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,0.505322477394365,
RKK2015_SC-514/basal,,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,0.5000072258201415,
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,,
HS2024_5_I_T3,0.49615487724364477,
KS2014_Intensity N1,0.49518057053184544,
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,0.4958664984276545,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,,
AH2018_SILAC_MR_2_C,0.4964847817838217,
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,,
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,0.5007747689556994,
JJ2018_Ratio H/M normalized___1,,
RCJD2014_15min_2,0.4988466381063828,
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,,
HS2024_5_B_N2,0.49702935855603286,
HS2024_5_I_N1,0.5034597140998025,
HS2024_6_I_N1,0.49550473922209404,
AR2021_KD 48h,0.5019074611254001,
FR2021_Intensity.B,,
RB2022_3_PreEndurance,,
HS2024_5_I_T1,0.4998766024971759,
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,,
AST2020_anti-CD3,0.4954221397095935,
SR2019_MDAMB231_Biol_repl_1,,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,0.5015404311551361,
KBE2022_Log2_Ex_29_U,0.4993209348575773,
HS2024_7_B_T1,0.5008412206702879,
AH2018_LFQ_M_2_X,0.49781542423597275,
AH2018_LFQ_IT_4_N,0.4948914869924375,
CK2022_15 200-1,0.5019766429042314,
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,,
JJ2018_Ratio M/L normalized pP3___1,,
KBE2022_Log2_Ex_34_T,0.49784869804996695,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,0.49731544895395174,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,0.4981035443177081,
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),0.4976693674879467,
WZ2023_Su_010_30min,0.4919011757232368,
RN2012_H01,,
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,,
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,,
EP2017_Pervanadate R#1 normalized log2 ratio,0.4975946138007148,
HS2024_8_B_T3,0.4983009005000264,
YA2020_Reporter_intensity_Cancer_No.3,0.4960405984974388,
KBE2022_Log2_Ex_44_U,0.49837845805331865,
WZ2023_Pe_010_20min,0.506796366714127,
KS2014_Intensity pY_C6,,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,0.5025179146997544,
RB2022_3_PreStrength,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,0.5004907819165088,
KS2014_Intensity C1,0.49786389931190145,
FSO2013_Ratio H/M normalized Rep3___1,0.4937079683495527,
AH2018_SILAC_M_3_C,0.4964491378846967,
RKK2015_TNF-α+IKKb/TNF-α,,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,0.4971529216789054,
AH2018_SILAC_M_2_X,0.49593081714637266,
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,,
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,0.488101047175228,
PG2020_Intensity 6h_C,,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,
JJ2018_Ratio M/L normalized pP1___1,,
AH2018_LFQ_M_3_N,0.49831031945370596,
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,0.49954586212641233,
CK2022_15 16-1,0.4985503232369562,
CK2022_3 16-1,0.49738250549623597,
LY2019_P4-,0.4969109245099012,
FSO2013_Ratio H/L normalized Rep3___2,0.5045598821594901,
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,0.5018482964642904,
GF2025_P8_Adh,0.50043109540482,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,0.49712262073700786,
CK2022_10 16-1,0.49680222818238634,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),0.49750306710657866,
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,,
SAS2015_AZD/DMSO_Exp2,,
IMM2018_normalised rep. int. CDK5L-1,0.4973236714796884,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,0.4888484043531047,
EJN2021_2_Ex_Basal,,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,,
AR2021_L41 10 μM,0.49994621758369123,
CF2017_EOC 2,,
RB2022_6_PostEndurance,,
AH2018_SILAC_1_N,,
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,,
RB2022_7_PreSprint,0.4969993401470637,
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,0.5043925018943106,
CK2022_6 16-1,0.4978726700380489,
ZX2022_CB treated Replicate 1,0.4972789719483867,
BS2014_Log2(Ratio H/L normalized Rep_3),,
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,0.5008315539448499,
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,0.49871483098623287,
RB2022_1_PreStrength,0.4997193863666418,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,0.49963933912863534,
AR2021_L41 1 μM,0.5021380911403004,
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,0.4987531865956017,
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,
ZX2022_Control Replicate 3,0.49748403157401905,
KS2014_Intensity C4,0.4987906782870802,
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,0.4989480472180825,
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,0.4975304135025539,
MV2014_Ratio H/M normalized B2___1 (5 min),0.4978056005838923,
FSO2013_Ratio M/L normalized Rep2___3,0.5096941605441587,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,0.4995411099847239,
SR2019_MCF10A_Biol_repl_3,,
HS2024_7_B_T2,0.4983261101541627,
SAS2015_PLX/DMSO_Exp3,,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,0.4984720791483462,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,0.49614029247808666,
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,0.4953074833674924,
AH2018_SILAC_IT_3_C,0.4989835118731715,
WZ2023_Pu_025_10min,0.5035838201607482,
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,0.4992000468660087,
FSO2013_Ratio M/L normalized Rep3___1,0.4943734767682048,
SR2019_JIMT1_Biol_repl_4,,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,,
CF2017_EOC 4,,
JJ2018_Ratio H/L normalized pP1___1,,
WZ2023_Pe_010_30min,0.5038885977806761,
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,0.49568704748519204,
KS2014_Intensity C6,0.4982887886074783,
ZQ2022_N3,,
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,0.5000652121359381,
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,0.49841173926127935,
JJ2018_Ratio H/M normalized pP1,,
CK2022_16 40-1,0.5010102674585512,
AH2018_SILAC_IT_2_C,0.49894816442222817,
CK2022_5 40-1,0.5000392646177005,
AH2018_LFQ_3_X,0.4976058657302071,
UK2020_UA_3,,
LY2019_P7-,0.49343237295945247,
GF2025_P5_Adh,0.497586492995179,
RB2022_1_PostStrength,,
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,0.4998441982610581,
SR2019_HCC1954_Biol_repl_3,,
CR2017_Ratio Replicate 2.2,0.4942619240529926,
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),0.4942265557701917,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,0.49731822208810167,
ZQ2022_C1,,
CR2017_Ratio Replicate 2.1,0.5050146047638564,
PG2020_Intensity CT_B,,
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,0.5032455486344042,
KS2014_Intensity pY_E5_1,,
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,0.4989073946939595,
AH2018_LFQ_3_C,0.4977734207663126,
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,0.4983178973973736,
YA2020_Reporter_intensity_Cancer_No.4,0.49628117751648165,
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,0.493649156353503,
RB2022_2_PreEndurance,,
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,0.497577866469563,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),0.4897262099450997,
JJ2018_Ratio M/L normalized___1,,
FR2021_Intensity.H,0.496093095547257,
CK2022_14 16-1,0.4986849610557418,
AST2020_anti-CD3+PDL2,0.49542897236550903,
MV2014_Ratio M/L normalized B1___1 (5 min),0.4958116572287125,
KBE2022_Log2_Ex_19_T,,
KS2014_Intensity pY_N1,,
RB2022_1_RecoveryEndurance,0.49730410762476857,
FSO2013_Ratio H/M normalized Rep1___2,0.49294812900762364,
HS2024_8_I_T1,0.49682655873707593,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,0.4903958154647458,
AH2018_TMTMS2_1_X,0.4987019505478445,
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,,
HS2024_6_I_N2,0.49511755328329854,
HH2022_Reporter intensity 4,0.49568150561520524,
RBK2021_1326T Late,,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,0.49293836353877984,
MV2014_Ratio L/H normalized B3___2 (5 min),0.4966216978640023,
LG2023_Control-3_intensity,,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,0.49837872892656443,
HS2024_4_I_T3,0.4977569646966032,
AH2018_SILAC_1_X,,
PG2020_Intensity 10h_B,,
AH2018_TMTMS3_1_X,0.49279579494150133,
CF2017_FTE 14,,
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,,
SR2019_HCC1419_Biol_repl_3,,
KBE2022_Log2_Ex_14_T,,
EP2017_Untreated R#2 normalized log2 ratio,0.49409959922558305,
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,0.49820378320454295,
HS2024_5_I_N2,0.5037490318289212,
SAS2015_PLX/AZD_Exp3,,
EP2017_Pervanadate R#2 log2 ratio,0.49357180372604953,
AS2011_Ratio H/L Normalized RNAi_2_1,,
